This week, the U.S. House of Representatives will be out of session, as the chamber has adjourned for the August 2025 district work period. The U.S. Senate remains in session and continues to consider nominations to lead...more
7/30/2025
/ Affordable Care Act ,
Artificial Intelligence ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Federal Funding ,
Health Care Providers ,
Health Insurance ,
Medicaid ,
New Legislation ,
Proposed Legislation ,
Senate Confirmation Hearings ,
Trade Agreements
With the One Big Beautiful Bill Act (OBBB) passed by U.S. Congress and signed into law, Congress now has less than three weeks that it will be in session before government funding expires on Sept. 30, 2025. Appropriators will...more
7/22/2025
/ Affordable Care Act ,
Appropriation ,
CBO Report ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Investigations & Hearings ,
Continuing Resolution ,
Department of Health and Human Services (HHS) ,
Executive Orders ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Healthcare ,
Medicare ,
National Institute of Health (NIH) ,
New Legislation ,
Outpatient Prospective Payment System (OPPS) ,
Physician Fee Schedule ,
Prescription Drugs ,
Proposed Rules
With the reconciliation package signed into law, the U.S. House of Representatives is in recess and will return on July 14, 2025. In the interim, the U.S. Senate will focus on the appropriations bills for fiscal year (FY)...more
7/10/2025
/ Affordable Care Act ,
Appointments Clause ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Constitutional Challenges ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Healthcare Reform ,
HRSA ,
Medicaid ,
Medicare ,
New Legislation ,
SCOTUS ,
Section 340B ,
Transgender ,
Trump Administration
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
3/12/2025
/ Affordable Care Act ,
CBO Report ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Federal Funding ,
Food and Drug Administration (FDA) ,
General Services Administration (GSA) ,
GRAS ,
Health Care Providers ,
Legislative Agendas ,
Medicare ,
Tariffs
Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
1/23/2025
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Constitutional Challenges ,
Department of Health and Human Services (HHS) ,
Federal Trade Commission (FTC) ,
Health Information Technologies ,
Health Insurance ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
MedPAC ,
New Legislation ,
Public Health ,
Regulatory Agenda ,
SCOTUS ,
Telemedicine ,
Trump Administration